In a study by Zhu et al., the author demonstrated that heme oxygenase 1 (HMOX1) reduces the sensitivity of HCC cells to sorafenib via regulation of the ABC transporter’s expression [103]. Here, ABCG2 is linked to hepatocellular carcinoma.